Literature DB >> 34481976

Microbial production of riboflavin: Biotechnological advances and perspectives.

Jiajia You1, Xuewei Pan1, Chen Yang1, Yuxuan Du1, Tolbert Osire1, Taowei Yang1, Xian Zhang1, Meijuan Xu1, Guoqiang Xu2, Zhiming Rao3.   

Abstract

Riboflavin is an essential nutrient for humans and animals, and its derivatives flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are cofactors in the cells. Therefore, riboflavin and its derivatives are widely used in the food, pharmaceutical, nutraceutical and cosmetic industries. Advances in biotechnology have led to a complete shift in the commercial production of riboflavin from chemical synthesis to microbial fermentation. In this review, we provide a comprehensive review of biotechnologies that enhance riboflavin production in microorganisms, as well as representative examples. Firstly, the synthesis pathways and metabolic regulatory processes of riboflavin in microorganisms; and the current strategies and methods of metabolic engineering for riboflavin production are systematically summarized and compared. Secondly, the using of systematic metabolic engineering strategies to enhance riboflavin production is discussed, including laboratory evolution, histological analysis and high-throughput screening. Finally, the challenges for efficient microbial production of riboflavin and the strategies to overcome these challenges are prospected.
Copyright © 2021 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ashbya gossypii; Bacillus subtilis; Dynamic regulation; Metabolic engineering strategy; Riboflavin; Systems approaches

Mesh:

Substances:

Year:  2021        PMID: 34481976     DOI: 10.1016/j.ymben.2021.08.009

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  1 in total

1.  Cheese whey supports high riboflavin synthesis by the engineered strains of the flavinogenic yeast Candida famata.

Authors:  Justyna Ruchala; Yuliia A Andreieva; Andriy O Tsyrulnyk; Svitlana M Sobchuk; Alicja Najdecka; Liu Wen; Yingqian Kang; Olena V Dmytruk; Kostyantyn V Dmytruk; Dariya V Fedorovych; Andriy A Sibirny
Journal:  Microb Cell Fact       Date:  2022-08-13       Impact factor: 6.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.